I sincerely hope NoRetread is wrong over at the other place. He's figuring that the entire defensin mimetic platform will be worth 750 Million AFTER B positive P3 results. That seems way off for a novel drug and the entire platform of anti infectives...
Not sure where I land exactly in all of this valuation talk. I'm probably more optimistic (at least hopeful)!
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links